The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical efficacy of daratumumab (DARA)-based second line therapy after DARA-containing and DARA-free induction therapies in multiple myeloma: A single center experience.
 
Amanda Ciardiello
No Relationships to Disclose
 
Neha Korde
Honoraria - MedImmune
Consulting or Advisory Role - Cancer Network; Clinical Care Options/NCCN; OncLive/MJH Life Sciences; PER/CURE Media Group
Research Funding - Amgen; Janssen
 
Malin Hultcrantz
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Bristol-Myers Squibb/Celgene; Curio Science; Intellisphere
Research Funding - Amgen (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst)
 
Hani Hassoun
Consulting or Advisory Role - Novartis
Research Funding - Janssen; Takeda
 
Sham Mailankody
Honoraria - OncLive/MJH Life Sciences; Physicans' Education Resource; Plexus
Consulting or Advisory Role - Janssen Oncology; Legend Biotech
Research Funding - Alimera Sciences (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics; Fate Therapeutics; Janssen Oncology (Inst); Juno Therapeutics (Inst); Takeda (Inst)
 
Urvi A Shah
Honoraria - Association of Community Cancer Centers (ACCC); MashupMD; MJH Life Sciences; OncLive/MJH Life Sciences; Phillips Gilmore Oncology; RedMedEd
Consulting or Advisory Role - Janssen Oncology
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Plantable (Inst)
 
Sydney X. Lu
No Relationships to Disclose
 
Dhwani Patel
No Relationships to Disclose
 
Kylee Maclachlan
No Relationships to Disclose
 
Oscar Boutros Lahoud
Consulting or Advisory Role - MorphoSys
Travel, Accommodations, Expenses - MorphoSys
 
Gunjan L. Shah
Research Funding - Amgen (Inst); BeyondSpring Pharmaceuticals (Inst); Janssen (Inst)
 
Michael Scordo
Honoraria - i3 CME; Medscape
Consulting or Advisory Role - Angiocrine Bioscience; Kite/Gilead; McKinsey & Company; Omeros
Research Funding - Angiocrine Bioscience; Omeros (Inst)
Travel, Accommodations, Expenses - Kite/Gilead
 
David J. Chung
Research Funding - Genentech
 
Heather Jolie Landau
Consulting or Advisory Role - Amgen; Caelum Biosciences; Celgene; Clinical Care Options; HCA Healthcare; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Spectrum Pharmaceuticals; Takeda
Research Funding - Takeda
 
Sergio Giralt
Consulting or Advisory Role - Actinuum; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Jazz Pharmaceuticals; Kite/Gilead; Omeros; Pfizer; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Pfizer; Sanofi
 
Andriy Derkach
No Relationships to Disclose
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Oncopeptides; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; Trillium Therapeutics
Consulting or Advisory Role - Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Carlyn Rose Co Tan
Employment - Janssen Research & Development (I)
Stock and Other Ownership Interests - Janssen Research & Development (I)
Honoraria - PER/CURE Media Group
Consulting or Advisory Role - Janssen
Research Funding - Janssen